Loading...
XSTO
STIL
Market cap185mUSD
Dec 05, Last price  
193.50SEK
1D
2.11%
1Q
-15.87%
Jan 2017
322.49%
Name

Stille AB

Chart & Performance

D1W1MN
XSTO:STIL chart
P/E
29.87
P/S
3.05
EPS
6.48
Div Yield, %
Shrs. gr., 5y
13.23%
Rev. gr., 5y
29.47%
Revenues
570m
+93.27%
96,611,000100,818,00083,411,00089,909,00088,044,00089,095,00081,467,00083,479,00096,334,000121,818,000135,796,000156,673,000142,627,000187,087,000246,350,000294,893,000569,950,000
Net income
58m
+118.44%
-1,773,0005,275,0003,485,000-1,053,000-1,916,0003,288,0001,890,00010,496,00016,789,00014,193,00020,179,00022,879,0008,273,00016,097,00027,324,00026,646,00058,206,000
CFO
74m
+97.27%
3,257,000-797,0001,414,0001,079,0006,984,000-1,725,000-1,351,00010,749,00019,414,00018,946,00013,452,00025,811,00020,556,0007,278,00031,936,00037,277,00073,535,000
Dividend
May 08, 20231.8 SEK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Stille AB develops, manufactures, and sells surgical instruments in Sweden and internationally. It offers artery forceps and ligature clamps; bone cutters and rongeurs; clamps, curettes, raspatories, elevators, forceps, and micro instruments; needle holders, and wire twisting and holding forceps; and osteotomes, chisels, retractors and skin hooks, scissors, and other products, as well as c-arm tables. The company also provides ERCP/abdominal fluoroscopy, neuro/spine, pain management, urology, and vascular surgeries. In addition, it provides instrument repair, maintenance, and inspection services. Further, the company's products are used in various open surgeries. It has a collaboration agreement with GE Healthcare and distribution agreement with Synovis Micro. The company sells through OEM manufacturers of C-frames, distributors, and direct sales. The company was founded in 1841 and is headquartered in Torshälla, Sweden. Stille AB is a subsidiary of Linc AB.
IPO date
Aug 29, 1997
Employees
103
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT